TearScan Lf
Aqueous-Deficient Dry Eye Disease
CommercialFDA 510(k) Cleared
Key Facts
Indication
Aqueous-Deficient Dry Eye Disease
Phase
Commercial
Status
FDA 510(k) Cleared
Company
About Axim Biotech
AXIM Biotechnologies is a diagnostic-focused R&D company with a mission to improve patient lives through rapid, in-clinic testing solutions. The company has achieved commercial validation with two FDA-cleared ophthalmological diagnostics and is leveraging its integrated platform to diversify into early cancer detection and cannabinoid research. Its strategy combines direct commercialization, strategic alliances, and a client-focused diagnostic development service to address unmet needs in multiple therapeutic areas.
View full company profile